Nathan Rice
Stock Analyst at Piper Sandler
(2.75)
# 2,054
Out of 5,057 analysts
60
Total ratings
44.74%
Success rate
7.45%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $37.65 | +27.49% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $32.50 | +29.23% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $27.50 | +27.27% | 9 | Oct 28, 2025 | |
| BFC Bank First | Maintains: Neutral | $137 → $142 | $125.18 | +13.44% | 9 | Oct 23, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $80.26 | -7.80% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $124.70 | -32.64% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $141.69 | +39.04% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $22.05 | -59.18% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $713.56 | -39.04% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $270.61 | -13.90% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $36.20 | +129.28% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $18.38 | -18.39% | 1 | Dec 19, 2019 |
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $37.65
Upside: +27.49%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $32.50
Upside: +29.23%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $27.50
Upside: +27.27%
Bank First
Oct 23, 2025
Maintains: Neutral
Price Target: $137 → $142
Current: $125.18
Upside: +13.44%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $80.26
Upside: -7.80%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $124.70
Upside: -32.64%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $141.69
Upside: +39.04%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $22.05
Upside: -59.18%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $713.56
Upside: -39.04%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $270.61
Upside: -13.90%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $36.20
Upside: +129.28%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $18.38
Upside: -18.39%